Friday, August 15, 2008: The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel by Kevin P. Bliden

Thursday, August 14, 2008: Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention:
Results From The EVENT Registry by Dr. Allen Jeremias

Thursday, August 14, 2008: Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients With Stable and Unstable Angina Undergoing PCI: ISAR-REACT 3 by Dr. Adnan Kastrati

Tuesday, July 1, 2008: Intracoronary Compared with Intravenous Bolus Abciximab Application in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Coronary Intervention: LIPSIAbciximab-STEMI by Dr. Holger Thiele

Monday, June 30, 2008: Rivaroxaban for Thromboprophylaxis After Total Knee Arthroplasty: RECORD 3 by Dr. Michael Rud Lassen

Monday, June 30, 2008: Oral rivaroxaban compared with subcutaneous enoxaparin for extended thromboprophyl axis after total hip arthroplasty: RECORD 1 by Dr. Bengt I Eriksson

Wednesday, June 25, 2008: Extended thromboprophylaxis with oral rivaroxaban versus short-term subcutaneous enoxaparin following total hip replacement: RECORD2 by Dr. Ajay K Kakkar

Friday, May 23, 2008: HORIZONS AMI 30 Day Results by Dr.Gregg Stone

Thursday, May 22, 2008: NOBORI 1 - Long Term Results Two Years Phase 1, One Year Phase 2 presented by Dr. Bernard Chevalier

Thursday, May 22, 2008: Slides from the PRoFESS Trial presented by Drs. Ralph Sacco, Salim Yusuf, and Hans-Christoph Diener at the 17th European Stroke Conference (ESC) in Nice, France

Thursday, May 22, 2008: SPIRIT III Trial, 2-Year Clinical Follow-up presented by Dr. Gregg W. Stone

Tuesay, May 20, 2008: Slides from the ATHENA Trial presented by Dr. Stefan H. Hohnloser, at Heart Rhythm 2008 in San Francisco

Tuesday, May 13, 2008: A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease by Dr. Jean G. Diodati

Thursday, April 17, 2008: Long-Term Safety of DES in Off-Label Use: Results of the MATRIX Registry by Dr. George D. Dangas

Thursday, April 17, 2008: Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction: The HORIZONS AMI Trial by Dr. George D. Dangas

Thursday, April 17, 2008: Impact Of Diabetes Mellitus On The Safety And Effectiveness Of Bivalirudin In Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty: The HORIZONS AMI Trial by Dr. Bernhard Witzenbichler

Thursday, April 17, 2008: Impact of gender on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The Horizons AMI Trial by Dr. L. Grinfield

Thursday, April 17, 2008: Impact of Baseline Renal Function on the Safety and Effectiveness of Bivalirudin in Patients with Acute MI Undergoing Primary Angioplasty: The HORIZONS AMI Trial by Dr. Roxana Mehran

Thursday, April 17, 2008: Impact of advanced age on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI Trial by Dr. Dariusz Dudek

Thursday, April 17, 2008: Major Adverse Events in STEMI Patients Treated with Primary Angioplasty Occur More Frequently at U.S. Compared with Non U.S. Sites: Analysis from the HORIZONS AMI Trial by Dr. Bruce R. Brodie

Thursday, April 17, 2008: Safety and effectiveness of bivalirudin compared to either abciximab or eptifibatide in patients with acute myocardial infarction undergoing primary angioplasty: The HORIZONS AMI Trial by Dr. Giulio Guagliumi

Monday, April 7, 2008: Trends in the Quality of Care of Patients with Acute Myocardial Infarction: The National Registry of Myocardial Infarction from 1990 to 2006 by Dr. Bimal R. Shah

Monday, April 7, 2008: Bridging Oral Anticoagulation with Low Molecular Weight Heparin: Experience in 367 Patients with Renal Insufficiency by Dr. Christoph Hammerstingl

Friday, April 4, 2008: Results of the Home Automated External Defibrillator Trial: HAT Trial by Dr. Gust H. Bardy

Thursday, April 3, 2008: Ongoing-Tirofiban In Myocardial Infarction Evaluation: ON-TIME-2 by Dr. Christian W. Hamm

Wednesday, April 2, 2008: REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction: Results of the REVERSE Trial by Dr. Cecilia Linde

Wednesday, April 2, 2008: Long-term Cardiac Arrhythmias recorded by Insertable Loop Recorders in Patients with depressed Left Ventricular Function after Acute Myocardial Infarction: CARISMA by Dr. PE Bloch
Thomsen

Wednesday, April 2, 2008: Effect of Rimonabant on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease: STRADIVARIUS by Dr. Steven E. Nissen

Wednesday, April 2, 2008: Is There a Critical Value of Daily Atrial Tachyarrhythmia Burden from Device Diagnostics that Raises Stroke Risk? The TRENDS Study by Dr.Taya V. Glotzer

Wednesday, April 2, 2008: A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk Coronary Artery Bypass Graft Surgery: Main Results of the MEND-CABG II Trial by Dr. John H. Alexander

Wednesday, April 2, 2008: The Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) using an Injection Catheter Trial: SEISMIC Trial by Dr. Patrick W. Serruys

Tuesday, April 1, 2008: Anemia Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial  by Dr. Steven V. Manoukian

Tuesday, April 1, 2008:Major Bleeding Is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results From the ACUITY Trial by Dr. Steven V. Manoukian

Tuesday, April 1, 2008: Transfusion is Associated With Increased One-Year Mortality and Ischemic Events in Patients With ACS: Results from the ACUITY Trial by Dr. Steven V. Manoukian

Tuesday, April 1, 2008: Percutaneous Mitral Repair with the MitraClip® Device for Functional Mitral Regurgitation: Results from the EVEREST Study by Dr. James Hermiller

Tuesday, April 1, 2008: Ensure’s Vascular Closure Device Speeds Hemostasis: ECLIPSE Trial by Dr. S. Chiu Wong

Tuesday, April 1, 2008: COntrast media and NephroToxicitr following coronary Revascularization by AngioplaSTy: CONTRAST by Dr. Rainer Wessely

Tuesday, April 1, 2008: Prospective, multicenter, randomized, double blind trial investigating influence on PCI outcome of additional 600 mg clopidogrel load in patients on chronic therapy: ARMYDA-Reload by Dr. Germano Di Sciascio

Tuesday, April 1, 2008: UK Multi-Centre Trial In Atherosclerotic Renovascular Disease: ASTRAL Trial by Dr. Philip A. Kalra

Monday, March 31, 2008: Comparison of Pioglitazone vs. Glimepiride on Progression of Coronary Atherosclerosis in Patients with Type 2 Diabetes: PERISCOPE Trial by Dr. Steven E. Nissen

Monday, March 31, 2008: Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension: The ACCOMPLISH Trial

Monday, March 31, 2008: ONTARGET: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial by Salim Yusuf

Monday, March 31, 2008: The Astroid Trial: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden  by Dr. Christie M. Ballantyne

Monday, March 31, 2008: The Hypertension in the Very Elderly Trial (HYVET) by Dr. Nigel S. Beckett

Monday, March 31, 2008: Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease: MAIN-COMPARE Study by Dr. Seung-Jung Park

Monday, March 31, 2008: Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease: PEPCAD II ISR Study by Dr. Martin Unverdorben

Monday, March 31, 2008: Long-Term Safety of DES in Off-Label Use: Results of the MATRIX Registry by Dr. George D. Dangas 

Monday, March 31, 2008: A Randomized, Multi-center Study of the Pimecrolimus-Eluting and Paclitaxel-ElutinGCoronary Stent System in PatiENtswith De Novo LEsionSof the Native Coronary ArterIeS: The Genesis Trial by Dr. Stefan Verheye 

Monday, March 31, 2008: CREATE Multi-Center Clinical Registry 9-month Angiographic and 12-month Clinical Results by Dr. Yaling Han

Sunday, March 30, 2008: Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study: TAPAS by Dr. Felix Zijlstra

Sunday, March 30, 2008: MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute myocardial infarction studY: MULTISTRATEGY by Dr. Marco Valgimigli

Sunday, March 30, 2008: Drug-Eluting and Bare Metal Stenting for Acute Myocardial Infarction in Massachusetts by Dr. Lauri Mauri

Sunday, March 30, 2008: Abciximab in Patients with AMI Undergoing Primary PCI After Clopidogrel Pretreatment: BRAVE-3 Trial by Dr. Julinda Mehilli

Sunday, March 30, 2008: Vascular Protection in High-Risk Non-ST Elevation Acute Coronary Syndromes: Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire by Dr. Mark Webster

Saturday, March 29, 2008: Comprehensive Meta-Analysis of DES vs. BMS Randomized Trials and Registries by Dr. Ajay J. Kirtane

Saturday, March 29, 2008: Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients With Stable and Unstable Angina Undergoing PCI: ISAR-REACT 3 by Dr. Adnan Kastrati

Saturday, March 29, 2008: Eight Months Angiographic Follow-up in Patients Randomized to Crush or Culotte Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Stent Technique Study by Dr. Pål Gunnes

Saturday, March 29, 2008: Long-Term Clinical Outcome After First Definite Stent Thrombosis: Dutch Stent Thrombosis Registry by Dr. J.W. van Werkum

Saturday, March 29, 2008: Percutaneous Coronary Interventions in Facilities without On-Site Cardiac Surgery: A Report from the National Cardiovascular Data Registry (NCDR)

Saturday, March 29, 2008: Prasugrel Compared to Clopidogrel in Patients with Acute Coronary Syndromes Undergoing PCI with Stenting: the TRITON - TIMI 38 Stent Analysis by Dr. Stephen D. Wiviott

Saturday, March 29, 2008: Adjusted Clopidogrel Loading Doses According to VASP Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel low response: A Multicentre Randomized Prospective Study by Dr. Laurent Bonello

Friday, March 28, 2008: Comprehensive Meta-Analysis of DES vs. BMS Randomized Trials and Registries by Ajay J. Kirtane, M.D., S.M. and Gregg W. Stone, M.D.

Monday, March 17, 2008: Statistics for the Interventionalist by Dr. Gregory J. Dehmer

Tuesday, March 11, 2008: The Total Artificial Heart:An Evolving Role in the Management of End-Stage Heart Failure by Dr. Marvin J. Slepian

Monday, March 3, 2008: In-stent Restenosis and Late Stent Thrombosis by Dr. Roxana Mehran

Wednesday, February 27, 2008: Contrast Induced Nephropathy: Predictors, Prevention, and Management by Dr. Roxana Mehran

Friday, February 22, 2008: Hemodynamics for the Interventional Cardiologist by Dr. Gregory Dehmer

Thursday, February 14, 2008: Update on Novel Antiplatelet Agents Under Advanced Clinical Development by Dominick J. Angiolillo, MD, PhD, FACC, FESC

Thursday, February 14, 2008: A Randomized Study Assessing the Impact of Cilostazol on Platelet Function Profiles in Patients with Diabetes Mellitus and Coronary Artery Disease on Dual Antiplatelet Therapy: Results of the OPTIMUS-2 (Optimizing anti-Platelet Therapy In diabetes MellitUS) Study by Dominick J. Angiolillo, MD, PhD

Thursday, February 14, 2008: Antiplatelet Resistance: What Does it Mean
and What Should/Can we do About it? by Dominick J. Angiolillo, MD, PhD, FACC, FESC 

Friday, December 21, 2007: False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention by David M. Larson

Friday, December 7, 2007:  PRasugrel IN Comparison to Clopidogrel for Inhibition of PLatelet Activation and AggrEgation Results from the PRINCIPLE - TIMI 44 Study

Wednesday, November 14, 2007: Regional STEMI Networks in Southern California Reduce Door-to-Balloon Times: Pooled Data from 4 Counties Results from the Southern California STEMI Consortium by Ivan Rokos   View the PDFof the LA Basin STEMI receiving centers

Friday, November 9, 2007: Long Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts by Laura Mauri

Wednesday, November 7, 2007: Impact of Thromboaspiration during Primary PCI on Microvascular Damage and Infarct Size: Acute and Long term CE-MRI Evaluation Results from the EXPIRA Trial by Gennaro Sardella

Wednesday, November 7, 2007: A Randomized Trial of Genotype-uided versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation Results from the Couma-Gen Study by Jeffrey L. Anderson

Tuesday, November 6, 2007: The Resynchronization Therapy in Normal QRS (RethinQ) Study by John F. Beshai

Monday, November 5, 2007: Bivalirudin With and Without Eptifibatide for Elective Stenting: A Pharmacodynamic Study of Platelet Reactivity in Relation to the Occurrence of Periprocedural Myocardial Infarction Results from the CLEAR PLATELETS-2 Study

Monday, November 5, 2007: Results of the RACE Project

BREAKING NEWS Sunday, November 4: Results of the TRITON- TIMI 38 Trial

Results of the BRIEF-PCI Trial by Anthony Fung

Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent Safety Results from the Endeavor by Laura Mauri

Results of the ARMYDA-5 Trial by Germano Di Sciascio

Results of the ARMYDA-4 Trial by Germano Di Sciascio

Evidence-Based Medicine Therapies in ACS: From Principles to Practice by Magnus Ohman

A Prospective, Randomized Trial of a Paclitaxel-Eluting Balloon in In-Stent Restenosis 2-Year Results from PACCOCATH ISR 1 and 2 by Bruno Scheller

TRA-PCI update on the new antiplatelet agents: PAR-1 inhibitors by David Moliterno

TAXUS ATLAS SMALL VESSEL and LONG LESION: First Report of Nine-Month Clinical and Angiographic Results by Mark Turco

Clopidogrel Response Variability and Resistance by Paul Gurbel

Eric Peterson provides an update on the CRUSADE and ACTION Registries

Benefits of aggressive lipid lowering before and after PCI and reperfusion by M. Gibson

Prolonged Infusion of Clevidipine Results in Safe and Predictable Blood Pressure Control in Patients with Acute Severe Hypertension Results from the VELOCITY Trial

A Prospective, Randomized Comparison of Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction 30 Day Results of the HORIZONS AMI Trial

Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty Results of the ARMYDA-5 Study

Impact of thrombectomy with EXPort catheter in Infarct Related Artery on procedural and clinical outcome in patients with AMI  The EXPIRA Trial

Thromboaspiration in Acute ST-Elevation MI Improves Myocardial Reperfusion EXPORT STUDY-First Report

A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease  1-Year Follow-Up and Subgroup Analysis for the SPIRIT III trial

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis ISAR-TEST 3 Randomized Trial

A Randomized Comparison of a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease The ENDEAVOR 4 Trial

Randomized Comparison between Sirolimus (Cypher)/Sirolimus-analogous (Xience; Promus) vs. Paclitaxel (Taxus vs.Costar) Eluting Stents in Coronary Lesions: a Single Center Experience The ABSOLUTE Trial

The European Randomized CoStar Trial: Cobalt-Chromium Paclitaxel-eluting Stent vs. identical BMS  Results of the EuroSTAR II Trial

Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty Results of the ARMYDA-4 Trial

A prospective randomized controlled study of the Medtronic Interceptor® PLUS Coronary Filter System for PCI of Degenerative SVG  Results of the AMEthyst Trial 

Effect of Distal Embolization on Myocardial Perfusion Reserve Following Percutaneous Coronary Intervention: A Quantitative MR Perfusion Study. Joseph Selvanayagam, M.D.

Patients with ACS undergoing PCI after randomization to Heparin plus GP IIb/IIIa Inhibitors Vs. Bivalirudin with or whitout GP IIb/IIIa Inhibitors. The results of the ACUITY PCI Trial. Harvey White, M.D.

Safety and Efficacy of Bivalirudin in Patients with Non-ST Elevation ACS undergoing Medical Management. One Year Results from the ACUITY Trial. Walter Desmet, M.D. 

Cardiac Magnetic Resonance in patients with acute MI.  Michael Shapiro, M.D., et al

Long term Follow-up  of the Diabetes I (DIABETes and Sirolimus Eluting Stent) Trial. Manel Sabate, M.D. et al. 

Drug Eluting Stents Vs. Bare Metal Stents in Sweden.  The Results of the SCAAR Trial. Stefan James M.D. et al.

Abciximab Vs. Placebo in Patients with NSTEMI undergoing PCI Aftrer Pretreatment with Clopidogrel.  The ISAR-REACT 2 Trial. The ISAR-REACT 2 Trial. M. Seyfarth M.D. et al

EuroHeart Survey Programme. The EUROASPIRE Surveys. Professor David A. Wood. et al.

Sirolimus Eluting Stents Vs. Bare Metal Stents Implantation Assisted by Systematic GP IIb/IIIa Infusion in Patients with MI. The STRATEGY Trial. Marco Valgimigli M.D.et al

Safety and efficacy of Intravenous Enoxaparin in Eective Percutaneous Coronary Intervention: An International Randomized Evalutaion. The STEEPLE Trial.  G. Montalescot  M.D. et al.

Efficacy Non-Invasive Ventilation in Patients with Acute Cardiogenic Pulmonary Edema. The 3 CPO Trial . David Newby M.D. et al.

Action in Diabetes and Vascular Disease . The ADVANCE Trial. S. MacMahon et al.

Substudy of Michelangelo: OASIS 5- Women's Substudy. Eva Swahn M.D.

5-year Outcome of the German Epidemiological Trial on Ankle Brachial Index. The  getABI Study. Curt Diehm, M.D.

Predictor of Response of CRT. The results of the PROSPECT Study. Cecilia Linde, M.D.

Western Norway B-vitamin Intervention Trial. The WENBIT Trial. Marta Ebbing, M.D.

Effect of Rosiglitazone on the Risk of Myocardial Infarction And Death from Cardiovascular Causes. George Diamond M.D. and Sanjay Kaul M.D.

 A Regionalized Approach to Patients with AMI . The Mayo Clinic Experience. Henry Ting M.D.http://clintrialresults.org/Slides/Ting STEMI Slides.ppt

Prognostic  Value of B-Type Natriuretic Peptides in Patients with stable Coronary Artery Disease, the Results of the PEACE Trial.  Professor Torbjorn Omland

The FAST Trial . Femoral Artery Stenting Trial.  Hans Krankenberg M.D.  and Michael Schlüter, PhD

The EMERALD Trial - Diabetic Substudy  Steve Marso, M.D.

Impact on prior peripheral arterial disease and stroke outcomes of acute coronary syndromes and effect of evidence-based therapies (from the GRACE Registry)  Debabrata Mukherjee, M.D.

Angiographic estimates of myocardium at risk during acute myocardial infarction: A validation using cardiac MRI  José T. Ortiz M.D.

Long term events in DES: A specific focus on the treatment of diseased saphenous vein grafts from the randomized  Delayed-RRISC Trial   Pierfrancesco Agostoni M.D. and Paul Vermeersch M.D.

 
A Comparison Between Iodixanol and Iopamidol  in High Risk Patients for Contrast Reduced Nephropathy. Results of the CARE Trial. Richard Solomon M.D.

Red Cell distribution Width  as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the DUKE Databank.  Michael Felker, M.D.

The MULTI-STRATEGY Trial. Evaluation of single high-bolus dose tirofiban Vs. abciximab and SES Vs. BMS in acute MI. Marco Valgimigli, M.D.

The GRACE Registry. Combining warfarin after coronary stenting. Michael Nguyen, M.D.

Natural History of Lone Atrial Fibrillation. 30-year Follow-up Study. Paul A. Friedman, M.D.

Infarct Transmurality Size Assessed by Delayed Enhancement MRI: Time-to-Treatment, ST-Segment Resolution, and TIMI-Flow Grades.   Holger Thiele, M.D.

Impact of Platelet Reactivity Following Clopidogrel Administration on Drug Eluting Stent Thrombosis. David Antoniucci, M.D.

Interpreting COURAGE: One Interventional Cardiologist’s Perspective  Duane S. Pinto, M.D.

The PROGRESS-AMS Study.  Clinical performance and  angiographic results of  coronary stenting with  Absorbable Metal Stents.   Raimund Erbel, MD.

DEFER STUDY: 5-YEAR FOLLOW-UP A Multicenter Randomized Study to Compare Deferral Versus Performance of PCI of Non-Ischemia-Producing Stenoses. Nico H.J. Pijls, MD, PhD

PCI in Patients Receiving Enoxaparin or UFH Following Fibrinolytic Therapy for STEMI:PCI ExTRACT-TIMI 25. C. Michael Gibson, MD

CHARISMA: The CAPRIE-like Cohort.  Deepak Bhatt, MD. 

Three Year Result of Intracoronary Stand-alone Bolus Administration of Eptifibatide During Coronary Intervention Walid M. Hassan, MD. Hassan et al. Catheterization and Cardiovascular Interventions. 2007; 69 (6): S93.

Superiority of 600 mg of Clopidogrel as a Loading Dose: A MetaAnalysis Presented at SCAI 07. Biondi-Zoccai and Abbate et al

Clopidogrel Use and Death/MI After Stent Implantation in a Diabetic Population. Results from the SUNSET Registry. Somjot Brar MD, et al.

Review and Update for Practitioners: ACS, PCI and CABG in Women. Jeffrey J. Popma, MD.

Randomized Trial of Sirolimus Stent Vs Bare Metal Stent in Acute Myocardial Infarction. SESAMI Trial. Mauricio Menichelli, MD, et al.

Intracoronary Streptokinase After Primary Percutaneous Coronary Intervention. Murat Sezer, MD, et al.

Impact of DES on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from The CRUSADE Quality Improvement Initiative. Gogo Prospero M.D., et al.

White Blood Cell Count Secular trend and Mortality: The Baltimore Longitudinal Study of Aging.  Carmelinda dr.ssa Ruggiero M.D., et al.

COURAGE Clinical Outcomes Utilizing Revascularization and Aggressive Guideline-Driven Drug Evaluation. Bill Boden, M.D.

COURAGE Design and Baseline Characteristics of the COURAGE trial by Bill Boden

Dr. Bill Boden discusses the results of the COURAGE trial on C TV

AVERT Atorvastatin Versus Revascularization Treatments

PCI vs Conservative Therapy for Chronic CAD Results from Meta-Analysis 2005

Survival PCI vs Medical Management The answer may depend on patient risk

Risk Factor Profiling by Cardiac MRI: Can it be a reality?  Katherine C. Wu, MD.

Long-Term Prognosis Associated with Coronary Calcification Matthew J. Budoff, MD.

ADHERE: Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure Gregg C. Fonarow MD.

The CRUSADE National Quality Improvement Initiative: Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes. Adam H. Skolnick, MD.

Evaluation by Optical Coherence Tomography (OCT) of Neointimal Coverage of Sirolimus-Eluting Stent Three Months After Implantation Masamichi Takano, MD. et al

Analysis of 36 Reported Cases of Late Thrombosis in Drug-Eluting Stents Placed in Coronary Arteries. Ramin Artang, MD and Robert S. Dieter, MD. et al

TAXUS ATLAS WORKHORSE and DIRECT STENT First Report of Nine and Twelve Month Clinical and Angiographic Results. Mark A. Turco, MD and John A. Ormiston, MBChB

Randomized Early versus Late AbciXimab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) Mauro Maioli, M.D.

Clinical Implications of Clopidogrel non-responsiveness.  Dominick Angiolillo, MD, PhD

Post-Conditioning the Human Heart to Reduce Infarct Size. Michel Ovize, MD, PhD.

ACUITY 1 Year Results  A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the ACUITY Trial. Gregg W. Stone, MD

Randomized Double Blind Trial of Thrombin Receptor Antagonist (TRA) Moliterno et al

ARMYDA-ACS: Atorvastatin Pretreatment Improves Outcome in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

TRIUMPH The Tilarginine Acetate Injection in a Randomized International Study in Unstable Acute Myocardial Infarction Patients with Cardiogenic Shock Trial. Judith S. Hochman, M.D.

ARISE Aggressive Reduction of Inflammation Stops Events. Presented by Dr. Jean-Claude Tardif

Cardiovascular Risk with COX-IIs - MEDAL Program: Multinational Etoricoxib and Diclofenac Arthritis Long-term. Christopher P. Cannon, MD

Aliskiren and Valsartan for Antihypertensive Therapy. Presented by Dr. Suzanne Oparil

ECLIPSE Blood Pressure Control with Clevidipine Compared with Nitroglycerin, Sodium Nitroprusside, or Nicardipine in the Treatment of Peri-operative Hypertension Solomon Aronson, M.D.

ECLIPSE BP Control Blood Pressure Control is an Independent Predictor of Short-term Mortality in Cardiac Surgery Patients. Solomon Aronson, M.D.

RACE: Reperfusion in AMI in Carolina Emergency Departments. Christopher Granger, MD.

OASIS 6: Efficacy and safety of fondaparinux in elderly patients with STEMI. Ron J.G. Peters, MD.

Implications of Preoperative Thienopyridine Use Prior to Coronary Bypass Graft Surgery in Patients with ACS: A Report from the ACUITY Trial. Ramin Ebrahimi, MD.

ANTHEM-TIMI 32: Results of the Dose- Ranging and Heparin De-Escalation Phases of the ANTHEM-TIMI 32 Trial. Robert P. Giugliano, MD, SM.

ABSORB First-ever human trial of a fully bioabsorbable everolimus-eluting stent. Presented by Dr. Patrick W. Serruys

DEDICATION Distal protection using a Filterwire compared with conventional intervention among patients with STEMI undergoing PCI. Presented by Dr. Leif Thuesen.

ERASE Effect of rHDL on Atherosclerosis-Safety and Efficacy. Presented by Dr. Jean-Claude Tardif.

ILLUSTRATE Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation. Presented by Dr. Steven E. Nissen.

METEOR Measuring Effects of Intima-Media Thickness: An Evaluation of Rosuvastatin. Presented by Dr. John R. Crouse III. View an animated presentation.  View other resources

NAPA Nesiritide Administered Peri-Anesthesia in Patients Undergoing Cardiac Surgery. Mark J. Russo, MD, MS.

SPIRIT III  Clinical, Angiographic, and IVUS Results from the Pivotal U.S. Randomized SPIRIT III Trial of the XIENCE V Everolimus-eluting Coronary Stent System.  Gregg W. Stone, MD.

FUSION II Follow-Up Serial Infusions of Nesiritide for the Management of Patients With Heart Failure.

EVEREST Efficacy of Vasopressin antagonism in hEart failuRE: outcome Study with Tolvaptan (EVEREST).  Marvin A. Konstam, MD

Top Ten Clinical Trials of the Year: 2006

Emerging Data Regarding the Potential Benefits of Early Initiation of Clopidogrel Among ACS Patients. C. Michael Gibson, M.S., M.D.

New Approaches to Chronic Anticoagulation: Factor XA Inhibition. C. Michael Gibson, MS, MD.

LDL or HDL: Which is More Important?  Christopher P. Cannon, MD

Is It Safe To Switch Between Antithrombins? C. Michael Gibson, M.S., M.D.

Antiplatelet Therapy in ACS and PCI: Challenges and Future Directions. Stephen D. Wiviott, MD.

Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI. Duane S. Pinto, MD.

Appropriate Use of Lytics: Adherence to the Guidelines. W. Frank Peacock, MD, FACEP.

Pretreatment with Thienopyridines: Emerging Data Regarding the Potential Benefits of Early Initiation of Clopidogrel Among ACS Patients.  C. Michael Gibson, MS, MD

Targeting Hemoglobin and the Use of Erythropoietin and Transfusion in Cardiac Patients. Peter A. McCullough, MD, MPH, FACC, FACP.

Prognostic Implications of Bleeding and Transfusions in Acute Coronary Syndromes and Percutaneous Coronary Intervention. Steven V. Manoukian, M.D., F.A.C.C., F.S.C.A.I.

10 Lessons Learned from CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC and AHA Guidelines?  Eric D. Peterson, MD, FACC.

Coronary Revascularization in Diabetic Patients: Optimizing Outcomes in 2007. David J. Cohen, M.D., M.Sc.

Effect of Aspirin Dose on Platelet Reactivity in Diabetic Patients. Paul A. Gurbel, MD.

Are all Xa Inhibitors the Same?  Alexander G. G. Turpie, M.D.

Pay For Performance: What Does it Mean, What will be its Impact in CV Care. James Hoekstra, MD

Toxicity and Screening Recommendations for Amiodarone Use. Peter Zimetbaum, MD, FACC.